Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2024World Journal of UrologyOpen Access

PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJeremy KweMBMartin BaunackeKBKatharina Böehm

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kwe et al. (2024) studied this question.

synapsesocial.com/papers/68e78e2db6db6435876ff8dfhttps://doi.org/10.1007/s00345-024-04776-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1To Biopsy or Not Biopsy, That is the Question - PI-Rads 3 Prostate Lesions – Validation of Clinical and Radiological Parameters for Biopsy Decision-Making2025
  2. 2Natural History of PI‐RADS 3 Lesions on Serial Prostate mpMRI2026
  3. 3Enhancing Prostate Cancer Detection in PI-RADS 3 Cases: An In-depth Analysis of Radiological Indicators from Multiparametric MRI2024
  4. 4Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks Apart2025
  5. 5Limited Incremental Diagnostic Value of Perilesional and Systematic Biopsies in PI-RADS 4–5 Lesions: A Retrospective Single-Center Study2026